Analysts are estimating that Sanofi will report an earnings per share (EPS) of $1.39.
Anticipation surrounds Sanofi's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Historical Earnings Performance
In the previous earnings release, the company beat EPS by $0.07, leading to a 1.32% drop in the share price the following trading session.
Here's a look at Sanofi's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
0.86
0.94
1.50
2.26
EPS Actual
0.93
0.97
0.89
1.39
Price Change %
-1.0%
-0.0%
-2.0%
-19.0%
Market Performance of Sanofi's Stock
Shares of Sanofi were trading at $52.89 as of October 23. Over the last 52-week period, shares are up 23.12%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analysts' Take on Sanofi
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Sanofi.
Analysts have provided Sanofi with 1 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $60.0, suggesting a potential 13.44% upside.
Analyzing Ratings Among Peers
The below comparison of ...
